Introduction: Dyslipidemia, is one of the major risk factors for macrovascularand microvascular disease in diabetes. Cardiovascular disease, stroke nephropathy and neuropathy, is more common in patients with type 2 diabetes mellitus (T2DM). The relationship between glycated hemoglobin (HbA1c) levels and lipid profiles in patients with type 2 diabetes (T2DM) has been the subject of contradictory research. Aim: The study was aimed to assesses the correlation between lipid profile and HbA1c in T2DM patients. Methodology: A total of320 subjects were selectedfor the study, among them 160 were T2DM cases and 160 were healthy controls. HbA1c and biochemical and parameters were done on Allinity I Abbott (USA) fully automatic analyzer. Results: The comparison of the biochemical profiles of T2DM cases and healthy controls revealed that the former had higher levels of serum Triglycerides (TG), total cholesterol (TC), Low Density Lipoprotein (LDL), and low High-Density Lipoprotein (HDL) than the latter, with a trend that was statistically significant (p<0.001). When comparing T2DM cases to healthy controls, the glycemic profile (HbA1c and glucose fasting) was greater in the former group and was determined to be statistically significant (p<0.001). Conclusion: Our findings verified a strong relationship between HbA1C and TG, TC, LDL and HDL. We observed a substantial variation in the lipid profile between the two HbA1C groups. Nevertheless, glycated hemoglobin may serve as a useful predictor of dyslipidemia in individuals with type 2 diabetes as well as a dependable biomarker of glycemic management.